UK markets close in 5 hours 44 minutes

Spero Therapeutics Inc (2HA.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.2300-0.0280 (-2.23%)
As of 11:00AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
17,667
96,735
48,579
3,070
258
-
Operating expenses
Research development
49,729
51,440
47,593
64,526
67,003
-
Selling general and administrative
43,009
25,554
36,483
41,701
21,440
-
Total operating expenses
101,593
69,948
79,146
91,041
79,371
-
Operating income or loss
-83,926
26,787
-30,567
-87,971
-79,113
-
Interest expense
4,545
0
2,605
1,940
0
-
Total other income/expenses net
-14,422
-5,320
-14,349
-191
432
-
Income before tax
-102,426
25,404
-46,415
-89,756
-78,280
-
Income tax expense
-
2,598
0
-
-
-
Income from continuing operations
-102,426
22,806
-46,415
-89,756
-78,280
-
Net income
-102,426
22,806
-46,415
-89,756
-78,280
-
Net income available to common shareholders
-102,426
22,806
-46,415
-89,756
-78,280
-
Basic EPS
0.39
-
-1.23
-2.91
-3.52
-3.35
Diluted EPS
0.39
-
-1.23
-2.91
-3.52
-3.35
Basic average shares
51,662
-
37,585
30,896
22,386
18,161
Diluted average shares
51,662
-
37,585
30,896
22,386
18,161